Skip to main content

November 2016

 

 

academics

 

Clinical research courses

Required for Assistant Manager - Drugs and Surgical in OSMCL | Government Job

Odisha State Medical Corporation Limited (OSMCL) has been incorporated on 8th November 2013 under the Companies Act., 1956, in pursuance to the Government Resolution No. 8844 dated 26th June 2013, to act as an independent procurement agency for the Department of Health and Family Welfare, Government of Odisha. The OSMCL has the key functions like timely procurement of quality medicines, surgical, equipment, instruments, furniture etc.through fair, transparentand competitive bidding process.

Post: Assistant Manager

Opportunity for Area Business Manager – Panacea Vaccines BU | B.Sc, B.Pharm, M.Sc, M.Pharm

Panacea Biotec is a leading research based Health Management Company, with an annual turnover of approx. Rs. 830 Crores. We are engaged in research, development, manufacture & marketing of Vaccines, Bio-Pharmaceuticals and Pharmaceuticals (Rx & OTC) of international quality and Health Services. All Panacea Biotec plants are accredited by international agencies and they follow current Good Manufacturing Practices, as per WHO guidelines.
We offer stimulating work environment & a career that spells growth. In tune with our plans, we require young, aggressive, dynamic, high performing and result oriented professional.

Post: Area Business Manager – Panacea Vaccines BU

5th Edition Pharma Innovation & Technology Summit 2016

Work as Project Coordinator /Manager at SRISTI

SRISTI is a developmental voluntary organization aiming to  strengthen the creativity of/at/for grassroots communities ,including individual innovators. It supports eco-friendly solutions to local problems being scouted, spawned and spread by the Honey Bee Network for over 26 years. It also nurtures ecopreneurs engaged in conserving biodiversity, common property resources, cultural diversity and educational innovators. There are five pillars of Honey Bee Network which SRISTI is committed to backstop: Educational innovations by school and college teachers, students and other stakeholders; institutional innovations at community and other levels in managing resources, improving access of knowledge  rich-economically poor people to trigger self reliant development process; cultural creativity so that curiosity, collaboration, and compassion growth through art, literature and crafts etc.

Post : Project Coordinator /Manager

Opportunity to work at Novartis as Group Leader- Data Management

Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Group Leader- Data Management

Job as Manager Group Procurement in Merck Pharma

Merck Limited (formerly E. Merck Limited) was set up in India as the first Merck subsidiary in Asia in 1967. The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post: Manager Group Procurement

Novartis ranked third in the 2016 Access to Medicine Index (up from 4th place in 2014), in recognition of its efforts to improve worldwide access to healthcare. The Index measures the performance of the top-20 pharmaceutical companies to improve access to medicines and healthcare in developing countries, and is conducted every other year. It covers seven categories, including access-to-medicine management, capacity building, pricing, manufacturing and distribution.

(adsbygoogle = window.adsbygoogle || []).push({});

Scientists from the National Institutes of Health have identified an antibody from an HIV-infected person that potently neutralized 98 percent of HIV isolates tested, including 16 of 20 strains resistant to other antibodies of the same class. The remarkable breadth and potency of this antibody, named N6, make it an attractive candidate for further development to potentially treat or prevent HIV infection, say the researchers.

Novartis announced  new data showing Cosentyx® (secukinumab) delivers sustained improvements in the signs and symptoms of psoriatic arthritis (PsA) over three years - including patient-reported pain. These findings were presented at the 2016 Annual Meeting of the American College of Rheumatology (ACR) in Washington DC, United States, at which Novartis presented 28 abstracts in total.

An experimental kidney cancer drug outperformed the standard first-line therapy for patients with metastatic disease who are considered at risk for poorer than average outcomes, according to results of a randomized phase II clinical trial by researchers at Dana-Farber Cancer Institute.